Role of SPECT Scan in Metastatic Prostate Cancer

Primary Applications of SPECT in Metastatic Prostate Cancer

SPECT is a nuclear medicine technique that uses radioactive compounds with affinity for bone matrix to detect areas of increased metabolic activity that may represent metastatic disease, particularly in late-stage metastatic prostate cancer, with the National Comprehensive Cancer Network recommending its use 2, 3
SPECT provides three-dimensional imaging capability, improving upon traditional planar bone scans by allowing better characterization of lesions, with the American College of Radiology noting its superiority 1
Bone metastases are common in late-stage metastatic prostate cancer, particularly in castration-resistant prostate cancer (CRPC), with >90% of CRPC patients having bone metastases, according to the American College of Radiology 4, 5

Bone scan (which may include SPECT) is indicated in the initial evaluation of patients at high risk for skeletal metastases, including those with T1 disease and PSA ≥ 20 ng/mL, T2 disease and PSA ≥ 10 ng/mL, Gleason score ≥ 8, T3/T4 disease, or any stage disease with symptoms suggestive of osseous metastatic disease, as recommended by the National Comprehensive Cancer Network 2, 3
SPECT is valuable in monitoring treatment response in metastatic prostate cancer patients, particularly when PSA is not a reliable marker of disease status, such as during androgen deprivation therapy (ADT), with the American College of Radiology noting its utility 4, 5

Higher sensitivity for detecting bone metastases compared to planar bone scans, with the American College of Cardiology noting its superiority, and the ability to detect lesions not seen by CT in some cases 1
Provides quantitative assessment of active bone metastatic burden through metrics like Total Bone Uptake (TBU), although this is not always a direct citation, the American College of Radiology recommends its use 1

SPECT imaging is slow, allowing imaging of only one or two anatomic segments over 30 minutes, and bone scan with SPECT only examines bones and will miss lymphatic or visceral metastases, with the American College of Radiology noting these limitations 1
Can show a flare phenomenon after treatment initiation that could lead to false interpretation of progression, with the American College of Radiology recommending caution 4

SPECT and CT are often performed as complementary modalities for comprehensive staging, with the American College of Radiology recommending their combined use 4, 5
When conventional imaging (CT, bone scan, MRI) is negative in high-risk patients, next-generation imaging including SPECT/CT may add clinical benefit, with the American Urological Association noting its potential utility 7, 9